Efficacy and safety of certolizumab pegol in an unselected...

Inflammatory Bowel Diseases 2011 Vol. 17; Iss. 7

Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey

Stephan R. Vavricka, Alain M. Schoepfer, Georg Bansky, Janek Binek, Christian Felley, Martin Geyer, Michael Manz, Gerhard Rogler, Philippe de Saussure, Bernhard Sauter, Michael Scharl, Frank Seibold,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Year:
2011
Language:
english
Pages:
10
DOI:
10.1002/ibd.21521
File:
PDF, 282 KB
english, 2011
Conversion to is in progress
Conversion to is failed